Syneos to lay off 98 amid changing business needs

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/phototechno)
(Image: Getty/phototechno)
Syneos Health will be reducing operations at its Indianapolis, IN-based facility following ‘shifting customer needs,’ says spokesperson.

In a letter to the Indiana Department of Workforce development, Dislocated Worker Unit, inVentiv Health, Inc. (a Syneos Health group company) announced that it will be reducing its workforce at its Indianapolis, IN-based facility.

Per the letter​ – addressed May 30, 2018 – “changing business needs”​ require the company to reduce operations at the facility. Sixty days notice was given to employees on June 1st​ and terminations are expected to begin “on or about”​ July 31, 2018, continuing through August 14, 2018.

Ninety-eight employees will be affected by the workforce reduction.

“We value transparency with our employees. With that in mind, we proactively communicated with a sub-set of employees about potential changes to their jobs based on shifting customer needs,”​ a Syneos Health spokesperson told us in a statement.

“The decision to make such business changes is never easy, and we’re actively evaluating the potential to redeploy these employees on other customer engagements.”

The spokesperson said the company remains committed to providing its contract research organization (CRO) services in Indiana.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us


View more